Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare Biotechnology

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by upside80on Apr 17, 2018 2:05pm

109 Views

Post# 27899060

RE:RE:RE:RE:Sheep have been herded and slaughtered

K scaley whatever I truely don't care what you think, I have no interest arguing with someone on SH BB, enjoy your bag, the small profit I made here was rolled into another stock that is up 20%.

To those of you that don't drink all the koolaid, you can see my April 04 post where I call a breakdown in the chart is a potential issue, I personally sold at .33 cents. Looks like I was right.

Next prediction this will bottom out in the low to mid teens and shares will need to be chewed through, take your time if you're looking to accumulate as there is likely no rush, there could be some large sell orders, I'd put bids in anywhere from .13 to .14 cents.

GLTA, remember to think for yourself.

Bullboard Posts

The top 10 Canadian medical stocks